MarginsXMarginsX
Home › Markets › Health Care › TVGN

Tevogen Inc. (TVGN)

TVGN trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.22
+3.67% on the day
Market cap
$422.2M
Small cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerTVGN on Nasdaq
SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CountryUnited States
IPO year2022
SEC CIK0001860871
SEC industry codeBiological Products, (No Diagnostic Substances)
Incorporated inDE

Financials

No annual revenue in SEC XBRL data for this filer.

Warning signs

Cash runway
1.1 months
$1.1M cash at June 30, 2026
Share count, 1 year
+65.5%
2025-08-13 to 2026-08-10
Going-concern doubt
No
10-Q filed August 14, 2026
Insider net buying, 12 months
-$7K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-14
Cash and burn$1.1M cash; operating cash flow -$2.9M a quarter.Report 2026-06-30
Shares outstanding6,511,540 (2026-08-10); 196,705,067 a year earlier. 1y figure adjusted for split (1-for-50 overall).Cover page 2026-08-10
Reverse splits, 3 years1; latest 1-for-50 on 2026-03-06Source 2026-03-06
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-06-12
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-04-22
AuditorKPMG LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-04-28
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $7K on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 67,880,267 shares at the 2026-11-13 price; the latest SEC cover count is 6,511,540 as of 2026-08-10. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$5.8M-$3.0M$1.1M$1.7MNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$5.4M-$2.7M$692K$1.7MNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed-$4.7M-$2.2M$0$1.7MNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$5.7M-$3.6M$1.0M$1.7MNeeds four quarters10-Q 2025-11-14
Q2 2025
2025-06-30
Not filed-$5.5M-$3.2M$685K$1.7MNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$10.4M-$3.3M$2.0M$1.7MNeeds four quarters10-Q 2026-08-14
Q4 2024
2024-12-31
Not filed-$9.4M-$3.0M$0$1.7MNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$5.9M-$3.8M$2.3M$1.7MNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-06-26
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-04
Latest proxyDEF 14A2026-08-03

Source: SEC EDGAR submissions feed, 310 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+7.3%
1 month-15.6%
3 months-8.7%
Year to date-63.7%
1 year-73.0%
From 52-week high-75.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
TVGNWTevogen Inc. Warrant$0.0256

Peers in Biotechnology: Biological Products (No Diagnostic Substances)

TickerCompanyPriceDayMarket cap
TECXTectonic Therapeutic Inc.$20.98-0.76%$418.5M
IRLAIRulya Therapeutics Inc.$37.36-6.13%$405.0M
SLBTSL Science Holding Limited$0.7195-3.42%$403.5M
FENCFennec Pharmaceuticals Inc.$12.76+9.81%$450.5M
CADLCandel Therapeutics Inc.$5.81-6.29%$455.8M
ALECAlector Inc.$2.57+1.18%$382.6M
RGNXREGENXBIO Inc.$7.32-4.19%$484.0M
CCCCC4 Therapeutics Inc.$2.65-3.99%$348.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier